Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
N. Marina, J. Algorta, G. Lopez-Vivanco, S. Carrera, M. Uribarri, S. Pedrero, U. Aresti, A. Gomez, R. Zalacain (Baracaldo, Zamudio, Spain). Are there potential characteristical markers in bronquial fluid for diagnosis of small cell lung cancer (SCLC)?. Eur Respir J 2009; 34: Suppl. 53, 2665

Member's Comments

No comment yet.

Related content which might interest you: Potential diagnostic markers in bronquial fluid of patients with non small cell lung cancer (NSCLC) Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009 Small cell lung cancer in patients with elderly Source: Annual Congress 2007 - Therapy of lung cancer Year: 2007 Giant non small cell lung cancer – diagnosis and treatment Source: Annual Congress 2008 - Congenital lung lesions and emphysema; lung cancer surgery Year: 2008 New cryobiopsy techniques influence the rate of diagnosis small cell lung cancer (SCLC) Source: Annual Congress 2010 - The role of endoscopy in the diagnosis of lung cancer Year: 2010 Symptoms, signs and staging of lung cancer Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=86 Year: 2001 Small cell lung cancer – possibility and difficulties in cytological diagnosis Source: Eur Respir J 2006; 28: Suppl. 50, 81s Year: 2006 Clinical course of asymptomatic small enhancing brain nodules in patients with nonsmall cell lung cancer: do we have to follow them up? Source: ERJ Open Res, 6 (3) 00109-2020; 10.1183/23120541.00109-2020 Year: 2020 Predicting activity of EGFR (epidermal growth factor receptor) inhibitors in diffuse bronchiolo-alveolar carcinoma or so-called pneumonic adenocarcinoma Source: Annual Congress 2006 - Bronchiolo-alveolar carcinoma Year: 2006 Should there be a specific management for large cell neuroendocrine carcinoma? Source: Annual Congress 2005 - Neuroendocrine tumours of the lung Year: 2005 Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy Source: Eur Respir J 2012; 39: 1437-1442 Year: 2012 Primay anaplasic large cell tumour of the lung in children Source: Annual Congress 2008 - The use of fibreoptic bronchoscopy in children with diffuse or localised lung disease Year: 2008 Clinical significance of serum cathepsin K level during chemotherapy of lung cancer. Can we use it as a marker of small cell lung cancer? Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology Year: 2008 Are there any peculiarities in tumour behavior and different tumour markers expression in nonsmall cell lung cancer? Source: Eur Respir J 2001; 18: Suppl. 33, 232s Year: 2001 New treatment options for nonsmall cell lung cancer and small cell lung cancer Source: Annual Congress 2006 - PG12 - Small cell lung cancer management Year: 2006 Cyclooxygenase(COX)-2 is over-expressed in non small cell lung cancer (NSCLC) and is a potential target for treatment Source: Eur Respir J 2002; 20: Suppl. 38, 400s Year: 2002 Symptoms and signs of lung cancer Source: Eur Respir Mon; 2009: 44: 71–87 Year: 2009 Molecular epidemiology in non small cell lung cancer (NSCLC) tumors: implication of gender and histological features Source: Eur Respir J 2006; 28: Suppl. 50, 335s Year: 2006